Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Developmental Origin of Oligodendrocyte Lineage Cells Determines Response to Demyelination and Susceptibility to Age-Associated Functional Decline.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.
Differential transcriptional response profiles in human myeloid cell populations.
The role of global and regional gray matter volume decrease in multiple sclerosis.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis.
Morphogenesis of the demyelinating lesions in Baló's concentric sclerosis.
Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Oligodendrocyte development and myelination in GFP-transgenic zebrafish.
Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases.
Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis ((DECIDE))
Time course of clinical and neuroradiological effects of delayed-release dimethyl fumarate in multiple sclerosis.
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.
Association Between Sleep Problems and Perceived Cognitive Dysfunction Over 12 Months in Individuals with Multiple Sclerosis.
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
AB Science announces recruitment of first patient in phase 3 study of masitinib in progressive multiple sclerosis
Fatigue and Comorbidities in Multiple Sclerosis.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Tract-specific and age-related variations of the spinal cord microstructure: a multi-parametric MRI study using diffusion tensor imaging (DTI) and inhomogeneous magnetization transfer (ihMT).
10 years of interferon beta-1b (Beta feron therapy.

Pages